Table 4.
Multivariate Analysis of Reported Symptom Prevalence
Annual visit | Problem visit | ||||||
---|---|---|---|---|---|---|---|
Outcome | Predictor | OR | 95% CI | p | OR | 95% CI | p |
Irregular/unpredictable periods | Case | 1.43 | 0.80–2.56 | 0.227 | 1.38 | 0.74–2.57 | 0.316 |
Postmenopause | 0.62 | 0.37–1.03 | 0.066 | 0.22 | 0.12–1.40 | <0.001a | |
Obese | 1.65 | 0.99–2.75 | 0.056 | 1.25 | 0.71–2.22 | 0.437 | |
Bleeding between periods | Case | 2.07 | 0.92–4.64 | 0.078 | 1.84 | 0.78–4.34 | 0.166 |
Postmenopause | 0.13 | 0.06–0.29 | <0.001a | 0.09 | 0.04–0.20 | <0.001a | |
Obese | 1.12 | 0.56–2.24 | 0.746 | 1.30 | 0.61–2.76 | 0.500 | |
Heavy periods | Case | 1.60 | 0.89–2.87 | 0.116 | 1.49 | 0.79–2.80 | 0.216 |
Postmenopause | 0.69 | 0.42–1.16 | 0.161 | 0.28 | 0.15–0.53 | <0.001a | |
Obese | 1.85 | 1.11–3.06 | 0.017a | 2.19 | 1.23–3.88 | 0.007a | |
Prolonged periods (>7 days) | Case | 3.01 | 1.51–6.03 | 0.002a | 1.75 | 0.88–3.51 | 0.112 |
Postmenopause | 0.28 | 0.14–0.53 | <0.001a | 0.19 | 0.10–0.37 | <0.001a | |
Obese | 1.31 | 0.71–2.43 | 0.392 | 1.46 | 0.78–2.72 | 0.233 | |
Bleeding after sex | Case | 3.02 | 1.04–8.75 | 0.042a | 0.99 | 0.39–2.54 | 0.986 |
Postmenopause | 0.25 | 0.09–0.69 | 0.008a | 0.25 | 0.11–0.59 | 0.002a | |
Obese | 0.66 | 0.24–1.79 | 0.417 | 1.21 | 0.53–2.77 | 0.657 | |
Bleeding after menopause | Case | 29.46 | 12.02–72.18 | <0.001a | 5.50 | 2.38–12.72 | <0.001a |
Obese | 1.43 | 0.60–3.39 | 0.417 | 1.65 | 0.78–3.47 | 0.191 | |
Pelvic pain | Case | 4.35 | 2.33–8.12 | <0.001a | 1.94 | 1.05–3.57 | 0.034a |
Postmenopause | 0.48 | 0.27–0.85 | 0.011a | 0.48 | 0.27–0.85 | 0.013a | |
Obese | 2.43 | 1.42–4.16 | 0.001a | 1.52 | 0.87–2.63 | 0.138 | |
Pelvic pressure | Case | 7.05 | 3.39–14.66 | <0.001a | 1.48 | 0.81–2.70 | 0.204 |
Postmenopause | 0.58 | 0.28–1.20 | 0.139 | 1.03 | 0.57–1.86 | 0.916 | |
Obese | 1.43 | 0.72–2.87 | 0.309 | 1.28 | 0.72–2.26 | 0.396 | |
Urinary frequency | Case | 2.32 | 1.29–4.19 | 0.005a | 1.21 | 0.68–2.18 | 0.519 |
Postmenopause | 2.48 | 1.38–4.45 | 0.002a | 1.35 | 0.78–2.37 | 0.285 | |
Obese | 1.87 | 1.07–3.26 | 0.028a | 1.53 | 0.89–2.63 | 0.123 | |
Bowel habits | Case | 1.40 | 0.77–2.56 | 0.275 | 1.11 | 0.60–2.04 | 0.744 |
Postmenopause | 1.30 | 0.74–2.30 | 0.363 | 0.96 | 0.53–1.72 | 0.884 | |
Obese | 1.87 | 1.07–3.26 | 0.027a | 1.76 | 0.99–3.12 | 0.052 | |
Discharge | Case | 9.41 | 4.68–18.92 | <0.001a | 3.32 | 1.79–6.15 | <0.001a |
Postmenopause | 0.51 | 0.26–1.03 | 0.060 | 0.80 | 0.44–1.46 | 0.470 | |
Obese | 1.63 | 0.85–3.11 | 0.138 | 1.22 | 0.68–2.18 | 0.499 | |
Fatigue | Case | 2.28 | 1.28–4.08 | 0.005a | 1.35 | 0.74–2.46 | 0.330 |
Postmenopause | 0.85 | 0.50–1.42 | 0.533 | 0.65 | 0.37–1.15 | 0.141 | |
Obese | 1.73 | 1.04–2.87 | 0.035a | 1.82 | 1.05–3.14 | 0.032a |
All models included terms for obesity, menstrual status, and case–control status.
p < 0.008 to control for multiple testing on primary objective.